Simó, Rafael http://orcid.org/0000-0003-0475-3096
Hernández, Cristina http://orcid.org/0000-0002-3109-1721
Funding for this research was provided by:
Universitat Autònoma de Barcelona
Article History
Received: 4 January 2023
Accepted: 31 March 2023
First Online: 6 June 2023
Authors’ relationships and activities
: D-Sight, a Vall d’Hebron Research Institute spin-off, holds intellectual property related to the use of ocular DPP-4 inhibitors to treat diabetic retinopathy. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.
: All authors were responsible for drafting the article and revising it critically for important intellectual content. All authors approved the version to be published.